OSIRIS THERAPEUTICS INC NEW - COM (OSIR)

CUSIP: 68827R108

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM
Total 13F shares
9,387,607
Share change
+557,119
Total reported value
$182,738,774
Put/Call ratio
20018%
Price per share
$19.46
Number of holders
86
Value change
+$11,012,292
Number of buys
53
Number of sells
27

Quarterly Holders Quick Answers

What is CUSIP 68827R108?
CUSIP 68827R108 identifies OSIR - OSIRIS THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OSIRIS THERAPEUTICS INC NEW - COM (OSIR) as of Q2 2015

As of 30 Jun 2015, OSIRIS THERAPEUTICS INC NEW - COM (OSIR) was held by 86 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,387,607 shares. The largest 10 holders included FMR LLC, Consonance Capital Management LP, BlackRock Fund Advisors, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., BAKER BROS. ADVISORS LP, STATE STREET CORP, NORTHERN TRUST CORP, Venator Capital Management Ltd., and SCHWAB CHARLES INVESTMENT MANAGEMENT INC. This page lists 86 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.